ResMed Inc. (ASX:RMD)

Market Cap	56.45B -3.0%
Revenue (ttm)	8.09B +9.6%
Net Income	2.23B +19.0%
EPS	15.16 +19.4%
Shares Out	n/a
PE Ratio	25.34
Forward PE	23.36
Dividend	0.34 (0.89%)
Ex-Dividend Date	Nov 12, 2025

Volume	1,308,307
Average Volume	1,077,708
Open	38.45
Previous Close	37.46
Day's Range	37.84 - 38.75
52-Week Range	32.04 - 45.25
Beta	0.88
RSI	53.43
Earnings Date	Jan 29, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD